Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-26 pm EDT 		5-day change 1st Jan Change
1.41 USD +1.77% Intraday chart for Inhibikase Therapeutics, Inc. -5.37% +11.02%
Jun. 17 Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease CI
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
Chart Inhibikase Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Static Chart